IRIS
LA MONICA, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 300
NA - Nord America 105
AS - Asia 75
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 485
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 145
US - Stati Uniti d'America 103
IE - Irlanda 59
FR - Francia 35
DE - Germania 25
CN - Cina 17
IN - India 15
BD - Bangladesh 8
JP - Giappone 7
VN - Vietnam 7
NL - Olanda 6
PL - Polonia 6
SG - Singapore 5
FI - Finlandia 4
GB - Regno Unito 4
KR - Corea 4
TR - Turchia 4
HK - Hong Kong 3
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
DZ - Algeria 2
HU - Ungheria 2
SE - Svezia 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
CA - Canada 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
KZ - Kazakistan 1
LB - Libano 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
TW - Taiwan 1
Totale 485
Salva come PNG Salva come JPEG
Città #
Dublin 59
Parma 42
Arezzo 18
Ann Arbor 12
Boardman 12
Ashburn 10
Medolla 10
Casina 9
Milan 8
Shanghai 8
Rome 7
Gdansk 6
Bremen 5
Neviano degli Arduini 5
Bottanuco 4
Dong Ket 4
Dorchester 4
Ellicott City 4
Helsinki 4
Indianapolis 4
Beijing 3
Delhi 3
Detroit 3
Hanoi 3
Los Angeles 3
Paris 3
Singapore 3
Waterville 3
Amstelveen 2
Antalya 2
Carate Brianza 2
Concord 2
Costa Mesa 2
Council Bluffs 2
Danbury 2
Florissant 2
Flushing 2
Gladbeck 2
Hangzhou 2
Houston 2
Jijelli 2
Nakayamadai 2
Osaka 2
Pavia 2
Pune 2
Rimini 2
Rockville 2
Sant'ilario D'enza 2
Serra 2
Slough 2
Szeged 2
Tokyo 2
Tübingen 2
Vadodara 2
Yongsan 2
Akola 1
Atlanta 1
Bacoli 1
Bangalore 1
Beirut 1
Bengaluru 1
Bologna 1
Borås 1
Brooklyn 1
Cagliari 1
Cambridge 1
Carlisle 1
Casalgrande 1
Cavaria Con Premezzo 1
Chandigarh 1
Chicago 1
Cincinnati 1
Cochabamba 1
Columbus 1
Correggio 1
Dallas 1
East Syracuse 1
Edmonton 1
Fayetteville 1
Fornovo Di Taro 1
Fort Lauderdale 1
Garching 1
Genoa 1
Genova 1
Harada 1
Hyderabad 1
Izmir 1
Jacksonville 1
Kingston 1
Kuala Lumpur 1
Köln 1
Lake Forest 1
Locate di Triulzi 1
London 1
Madrid 1
Manipal 1
Mcallen 1
Milpitas 1
Modena 1
Monterrey 1
Totale 358
Salva come PNG Salva come JPEG
Nome #
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib, file e177fbc7-275c-50b0-e053-d805fe0adaee 42
Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: review of the literature and future perspectives, file e177fbc7-9d28-50b0-e053-d805fe0adaee 36
New therapeutic strategies for malignant pleural mesothelioma, file e177fbc7-6d9a-50b0-e053-d805fe0adaee 35
Fighting tertiary mutations in EGFR-driven lung-cancers: Current advances and future perspectives in medicinal chemistry, file e177fbc7-9d62-50b0-e053-d805fe0adaee 33
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer, file e177fbc6-c828-50b0-e053-d805fe0adaee 32
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells., file e177fbc5-d274-50b0-e053-d805fe0adaee 31
null, file e177fbc4-3a65-50b0-e053-d805fe0adaee 28
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer, file e177fbc4-374a-50b0-e053-d805fe0adaee 26
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines, file e177fbc5-e007-50b0-e053-d805fe0adaee 21
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC, file e177fbc6-8be1-50b0-e053-d805fe0adaee 19
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines, file e177fbc4-3e0a-50b0-e053-d805fe0adaee 18
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells, file e177fbc6-9bb6-50b0-e053-d805fe0adaee 16
Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib, file e177fbc7-a512-50b0-e053-d805fe0adaee 16
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines, file e177fbc5-2589-50b0-e053-d805fe0adaee 15
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines., file e177fbc6-8938-50b0-e053-d805fe0adaee 14
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review, file e177fbc7-2761-50b0-e053-d805fe0adaee 14
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion, file e177fbc7-5975-50b0-e053-d805fe0adaee 11
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease, file e177fbc4-229b-50b0-e053-d805fe0adaee 9
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation, file e177fbc7-5aef-50b0-e053-d805fe0adaee 9
New therapeutic strategies for malignant pleural mesothelioma, file e177fbc5-6e69-50b0-e053-d805fe0adaee 6
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion, file e177fbc4-1fa1-50b0-e053-d805fe0adaee 5
Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation, file e177fbc7-1d2f-50b0-e053-d805fe0adaee 5
Fighting tertiary mutations in EGFR-driven lung-cancers: Current advances and future perspectives in medicinal chemistry, file e177fbc7-2765-50b0-e053-d805fe0adaee 5
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells, file e177fbc7-4245-50b0-e053-d805fe0adaee 5
Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation, file e177fbc7-5af1-50b0-e053-d805fe0adaee 5
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. (Cavazzoni and Bonelli co-first authors), file e177fbc4-2810-50b0-e053-d805fe0adaee 4
Synergistic activity of letrozole and sorafenib on breast cancer cells, file e177fbc4-1f38-50b0-e053-d805fe0adaee 3
Physico-chemical characterization and biological evaluation of two fibroin materials, file e177fbc5-1a5a-50b0-e053-d805fe0adaee 3
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer, file d9ef1511-b26b-4ec8-a599-23a03fa4141c 2
Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines, file e177fbc4-1f39-50b0-e053-d805fe0adaee 2
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN, file e177fbc5-953c-50b0-e053-d805fe0adaee 2
Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models, file e177fbc6-2696-50b0-e053-d805fe0adaee 2
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC, file e177fbc6-281f-50b0-e053-d805fe0adaee 2
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report, file e177fbc6-498c-50b0-e053-d805fe0adaee 2
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation, file e177fbc7-56f9-50b0-e053-d805fe0adaee 2
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine, file e177fbc7-9c8b-50b0-e053-d805fe0adaee 2
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification, file e177fbc4-3c48-50b0-e053-d805fe0adaee 1
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations., file e177fbc4-8faf-50b0-e053-d805fe0adaee 1
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells, file e177fbc6-03ea-50b0-e053-d805fe0adaee 1
Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells, file e177fbc7-a024-50b0-e053-d805fe0adaee 1
Totale 486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.629
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 1 0 0 0 0 0 0 0 0 0 0
2020/202116 0 0 0 0 0 1 0 1 3 0 2 9
2021/202272 2 21 0 6 3 0 20 1 3 2 3 11
2022/2023241 16 12 5 21 14 10 11 24 94 5 21 8
2023/202479 8 3 6 10 0 3 21 11 5 9 3 0
Totale 486